Many studies have shown that disordered intestinal flora in DKD patients lead to changes in the bile acid pool, metabolic disorders and abnormal expression of bile acid receptors; these phenomena subsequently affect host glucose metabolism and the immunoinflammatory response via different signaling pathways, thereby exacerbating kidney injury in DKD patients. This evidence concerns the gene NR1H4 and metabolic disease.